Zeitschriftenaufsatz
|
2014
Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.
Autor:in
Blatt, Katharina; Herrmann, Harald; Hoermann, Gregor; Willmann, Michael; Cerny-Reiterer, Sabine; Sadovnik, Irina; Herndlhofer, Susanne; Streubel, Berthold; Rabitsch, Werner; Sperr, Wolfgang R; Mayerhofer, Matthias; Rülicke, Thomas; Valent, Peter;
Publikationen als Autor:in / Herausgeber:in der Vetmeduni
Journal
Schlagwörter
Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal, Humanized/pharmacology; Antigens, CD/genetics*; Antigens, CD/metabolism; Antigens, Neoplasm/genetics*; Antineoplastic Agents/pharmacology; Bone Marrow/metabolism; Bone Marrow/pathology; Cell Line, Tumor; Cell Survival/drug effects; Cell Survival/genetics; Chromosome Aberrations*; Chromosome Deletion; Chromosomes, Human, Pair 5*; Disease Models, Animal; Disease Progression; Female; Gene Expression; Genes, ras; Glycoproteins/antagonists & inhibitors; Glycoproteins/genetics*; Humans; Immunophenotyping; Karyotype; Leukemia, Myeloid, Acute/diagnosis; Leukemia, Myeloid, Acute/drug therapy; Leukemia, Myeloid, Acute/genetics*; Leukemia, Myeloid, Acute/mortality; Male; Middle Aged; Myelodysplastic Syndromes/diagnosis; Myelodysplastic Syndromes/drug therapy; Myelodysplastic Syndromes/genetics*; Myelodysplastic Syndromes/mortality; Neoplastic Stem Cells/drug effects; Neoplastic Stem Cells/metabolism*; Phenotype; Xenograft Model Antitumor Assays;
Dokumententyp
Originalarbeit
ISSN/eISSN
1078-0432 -
10.1158/1078-0432.CCR-13-2811
WoS ID
PubMed ID